Work

Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Year: 2020

Type: article

Study design: Observational Study

Source: Metabolism

DOI: 10.1016/j.metabol.2019.12.072

Authors: E. Patorno, A. Pawar, J.M. Franklin, M. Najafzadeh, A. Déruaz-Luyet, K.G. Brodovicz, S. Sambevski, L.G. Bessette, M. Kulldorff, S. Schneeweiss

Institutions: Brigham and Women's Hospital, Harvard University, Boehringer Ingelheim (Germany), Boehringer Ingelheim (United States)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3010207927

FWCI:

Cites:

Cited by: 1

Related to: 10